Plans by the Drug Enforcement Administration (DEA) to classify kratom as a Schedule 1 drug have been temporarily halted amidst a lawsuit by a group of vendors. The resolution comes after impassioned advocates took to social media, and the scientific community voiced concerns over their ability to further research the plant. The DEA has reconsidered plan, which they made public on August 31, to place kratom into the super-restrictive category after it received more than 2,000 phone calls, most of which were opposed to it. The agency now plans to open up a public comment period where those who have used kratom for medical purposes can share their experiences and relay the plant’s clinical value.
Kratom Stays Off of Schedule 1 List Pending Further Inquiry published first on http://blog.rutexas.com
Kratom Stays Off of Schedule 1 List Pending Further Inquiry posted first on http://recoveryunpluggedtx.tumblr.com